Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Professional NewsFull Access

Psychotropic Drugs on the FDA’s Priority List (Drug/Indication)

Published Online:19 Jan 2001https://doi.org/10.1176/pn.36.2.0042a

alprazolam/anxiety

amphetamine/ADHD

bupropion/depression

buspirone/anxiety

citalopram/depression

clomipramine/OCD

clozapine/psychotic disorders

divalproex/mania

fluoxetine/OCD and depression

lorazepam/anxiety

methylphenidate/ADHD

mirtazepine/depression

modafanil/ADHD

naltrexone/substance abuse

nefazodone/depression

olanzapine/psychotic disorders

oxazepam/anxiety

paroxetine/OCD and depression

pemoline/ADHD

quetiapine/psychotic disordes

risperidone/psychotic disorders

sertraline/OCD and depression

trazodone/depression

valproate/mania

venlafaxine/GAD and depression

Source: FDA; Center for Drug Evaluation and Research, December 2000